An FDA advisory panel on Wednesday endorsed Grail's Galleri, a blood test to screen for multiple cancer types, voting 10–0 that it is reasonably safe, 6–4 that it is reasonably effective, and 7–2 with one abstention that its benefits outweigh its risks for patients who meet the proposed criteria. Th